425: Strive & Semler Scientific Merger Update

Strive, Inc. and Semler Scientific, Inc. provide an update on their proposed business combination, emphasizing forward-looking statements and shareholder information.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination.
• A communication regarding the merger was posted on X.com by Avik Roy, a Board Member of Strive, Inc., on October 24, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• The combined company anticipates strategic and financial benefits from the merger, including potential cost savings.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, with the SEC.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Sentiment

Score: 6

Explanation: The filing is primarily a procedural disclosure related to a merger announcement, heavily weighted with standard risk factors. While the underlying event (merger) is generally seen as strategic, the document itself is neutral to slightly positive due to its cautionary nature.

Positives

• Anticipated strategic benefits from the proposed transaction.
• Expected financial benefits from the proposed transaction, including anticipated cost savings.
• The ability to successfully integrate the combined businesses is a stated objective.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities due to the merger.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to unmet conditions.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The combined company anticipates realizing strategic and financial benefits, including cost savings, from the proposed business combination. The successful integration of the businesses is expected, though potential difficulties, increased costs, and longer timelines are acknowledged as risks. The timing of the closing of the proposed transaction is also a forward-looking expectation.

Management Comments

• Avik Roy, a Board Member of Strive, Inc., communicated on X.com on October 24, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Stakeholder Impact

• Shareholders of Semler Scientific will be asked to vote on the proposed transaction.
• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both companies may experience changes to business or employee relationships, potentially leading to adverse reactions.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, Bitcoin, digital assets, forward-looking statements, corporate governance